1. Beck AT, Alford BA. Depression: Causes and Treatment. Pennsylvania: University of Pennsylvania Press; 2009.
2. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005;62:1097–1106. PMID:
16203955.
3. Belmaker R, Agam G. Major depressive disorder. N Engl J Med 2008;358:55–68. PMID:
18172175.
4. Heim C, Binder EB. Current research trends in early life stress and depression: Review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol 2012;233:102–111. PMID:
22101006.
5. Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 2012;379:1045–1055. PMID:
22189047.
6. Rethorst CD, Toups MS, Greer TL, Nakonezny PA, Carmody TJ, Grannemann BD, et al. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol Psychiatry 2013;18:1119–1124. PMID:
22925832.
7. Fortunato RS, Ferreira AC, Hecht F, Dupuy C, Carvalho DP. Sexual dimorphism and thyroid dysfunction: a matter of oxidative stress? J Endocrinol 2014;221:R31–R40. PMID:
24578296.
8. Schutter DJ. The cerebello-hypothalamic-pituitary-adrenal axis dysregulation hypothesis in depressive disorder. Med Hypotheses 2012;79:779–783. PMID:
22999737.
9. Vargas HO, Nunes SOV, Barbosa DS, Vargas MM, Cestari A, Dodd S, et al. Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders. Life Sci 2014;102:65–71. PMID:
24607777.
10. Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science 2012;338:68–72. PMID:
23042884.
11. Lo Vasco VR, Polonia P. Molecular cytogenetic interphase analysis of Phosphoinositide-specific Phospholipase C β1 gene in paraffin-embedded brain samples of major depression patients. J Affect Disord 2012;136:177–180. PMID:
21880371.
12. Wu X, Kushwaha N, Banerjee P, Albert PR, Penington NJ. Role of protein kinase C in agonist-induced desensitization of 5-HT
1A receptor coupling to calcium channels in F11 cells. Eur J Pharmacol 2013;706:84–91. PMID:
23510743.
13. Boldrini M, Santiago AN, Hen R, Dwork AJ, Rosoklija GB, Tamir H, et al. Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression. Neuropsychopharmacology 2013;38:1068–1077. PMID:
23303074.
14. Smith R, Chen K, Baxter L, Fort C, Lane RD. Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex. J Affect Disord 2013;146:414–419. PMID:
23017544.
15. Heller AS, Johnstone T, Light SN, Peterson MJ, Kolden GG, Kalin NH, et al. Relationships between changes in sustained fronto-striatal connectivity and positive affect in major depression resulting from antidepressant treatment. Am J Psychiatry 2013;170:197–206. PMID:
23223803.
16. Hagihara H, Ohira K, Takao K, Miyakawa T. Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia. Mol Brain 2014;7:41PMID:
24886351.
17. Liu D, Sartor MA, Nader GA, Pistilli EE, Tanton L, Lilly C, et al. Microarray analysis reveals novel features of the muscle aging process in men and women. J Gerontol A Biol Sci Med Sci 2013;68:1035–1044. PMID:
23418191.
18. Barrett T, Edgar R. Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol 2006;411:352–369. PMID:
16939800.
19. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, et al. NCBI GEO: mining tens of millions of expression profiles-database and tools update. Nucleic Acids Res 2007;35:D760–D765. PMID:
17099226.
20. Bolstad BM, Irizarry RA, Åstrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185–193. PMID:
12538238.
21. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:Article3PMID:
16646809.
22. Hulsegge I, Kommadath A, Smits MA. Globaltest and GOEAST: Two Different Approaches for Gene Ontology Analysis. BMC Proceedings: BioMed Central Ltd; 2009.
23. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28:27–30. PMID:
10592173.
24. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44–57. PMID:
19131956.
25. Fan S, Hurd TW, Liu CJ, Straight SW, Weimbs T, Hurd EA, et al. Polarity proteins control ciliogenesis via kinesin motor interactions. Curr Biol 2004;14:1451–1461. PMID:
15324661.
26. Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, Li Y. A protein interaction map of Drosophila melanogaster. Science 2003;302:1727–1736. PMID:
14605208.
27. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, et al. STRING v9. 1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013;41:D808–D815. PMID:
23203871.
28. Kohl M, Wiese S, Warscheid B. Cytoscape: Software for Visualization and Analysis of Biological Networks. Data Mining in Proteomics. Springer; 2011.
29. MacQueen G, Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry 2011;16:252–264. PMID:
20661246.
30. Lemogne C, Delaveau P, Freton M, Guionnet S, Fossati P. Medial prefrontal cortex and the self in major depression. J Affect Disord 2012;136:e1–e11. PMID:
21185083.
31. Wang Q, Li W, Liu XS, Carroll JS, Jänne OA, Keeton EK, et al. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell 2007;27:380–392. PMID:
17679089.
32. Zitzmann M, Nieschlag E. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab 2007;92:3844–3853. PMID:
17635942.
33. Margolese HC. The male menopause and mood: testosterone decline and depression in the aging male--is there a link? J Geriatr Psychiatry Neurol 2000;13:93–101. PMID:
10912731.
34. Kheirkhah F, Hosseini SR, Hosseini SF, Ghasemi N, Bijani A, G Cumming R. Relationship between testosterone levels and depressive symptoms in older men in Amirkola, Iran. Caspian J Intern Med 2014;5:65–70. PMID:
24778779.
35. Basson R. Testosterone therapy for reduced libido in women. Ther Adv Endocrinol Metab 2010;1:155–164. PMID:
23148160.
36. Matsuzaka H, Maeshima H, Kida S, Kurita H, Shimano T, Nakano Y, et al. Gender differences in serum testosterone and cortisol in patients with major depressive disorder compared with controls. Int J Psychiatry Med 2013;46:203–221. PMID:
24552043.
37. Hajszan T, MacLusky NJ, Leranth C. Role of androgens and the androgen receptor in remodeling of spine synapses in limbic brain areas. Horm Behav 2008;53:638–646. PMID:
18262185.
38. Gosu V, Basith S, Durai P, Choi S. Molecular evolution and structural features of IRAK family members. PloS One 2012;7:e49771PMID:
23166766.
39. Saitoh T, Satoh T, Yamamoto N, Uematsu S, Takeuchi O, Kawai T, et al. Antiviral protein Viperin promotes Toll-like receptor 7-and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity 2011;34:352–363. PMID:
21435586.
40. Xiong Y, Qiu F, Piao W, Song C, Wahl LM, Medvedev AE. Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-β-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IκB kinase γ and increases A20 expression. J Biol Chem 2011;286:7905–7916. PMID:
21220427.
41. Haji N, Mandolesi G, Gentile A, Sacchetti L, Fresegna D, Rossi S. TNF-α-mediated anxiety in a mouse model of multiple sclerosis. Exp Neurol 2012;237:296–303. PMID:
22836148.
42. Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Luis Montejo A, Smeraldi E, et al. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry 2010;71:109–120. PMID:
20193645.
43. Dobos N, Korf J, Luiten PG, Eisel UL. Neuroinflammation in Alzheimer's disease and major depression. Biol Psychiatry 2010;67:503–504. PMID:
20185031.
44. Kim YK, Suh I, Kim H, Han C, Lim C, Choi S, et al. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry 2002;7:1107–1114. PMID:
12476326.
45. Loo YM, Gale M Jr. Immune signaling by RIG-I-like receptors. Immunity 2011;34:680–692. PMID:
21616437.
46. Lamont AG, Adorini L. IL-12: a key cytokine in immune regulation. Immunol Today 1996;17:214–217. PMID:
8991382.
47. Kim M, Park HL, Park HW, Ro SH, Nam SG, Reed JM, et al. Drosophila Fip200 is an essential regulator of autophagy that attenuates both growth and aging. Autophagy 2013;9:1201–1213. PMID:
23819996.
48. Robinson DR, Wu YM, Lin SF. The protein tyrosine kinase family of the human genome. Oncogene 2000;19:5548–5557. PMID:
11114734.
49. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 2005;57:252–260. PMID:
15691526.
50. Bayer TA, Schramm M, Feldmann N, Knable MB, Falkai P. Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2000;24:881–888. PMID:
11041531.
51. Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology 2012;22:736–756. PMID:
22183981.
52. Marucci A, di Mauro L, Menzaghi C, Prudente S, Mangiacotti D, Fini G, et al. GALNT2 expression is reduced in patients with Type 2 diabetes: possible role of hyperglycemia. PLoS one 2013;8:e70159PMID:
23894607.
53. Kennedy SH, Evans KR, Krüger S, Mayberg HS, Meyer JH, McCann S, et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001;158:899–905. PMID:
11384897.